The clinical efficacy of eribulin to soft tissue sarcoma patients: differences in histological subtypes

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2019-10, Vol.30, p.vi123-vi124
Hauptverfasser: Nakano, Kenji, Funauchi, Yuki, Hayakawa, Keiko, Tanizawa, Taisuke, Ae, Keisuke, Matsumoto, Seiichi, Takahashi, Shunji
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page vi124
container_issue
container_start_page vi123
container_title Annals of oncology
container_volume 30
creator Nakano, Kenji
Funauchi, Yuki
Hayakawa, Keiko
Tanizawa, Taisuke
Ae, Keisuke
Matsumoto, Seiichi
Takahashi, Shunji
description
doi_str_mv 10.1093/annonc/mdz343.027
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz343_027</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz343_027</sourcerecordid><originalsourceid>FETCH-LOGICAL-c857-a8464c80d6c9bd0f9c320f603c9c4b77987287c0f6dc80be2772ab496c2638253</originalsourceid><addsrcrecordid>eNotkL1OwzAUhT2ARCk8AJtfIK1jJ3HMhip-KlViyR45N3ZrlMSRrzOEp8dQpiOd8-kMHyFPOdvlTIm9niY_wX7sv0UhdozLG7JhiotMlqK4I_eIX4yxSnG1IefmYigMbnKgB2qsTQkr9Zaa4LolDTR6it5GGh3iYijqAH7UdNbRmSniM-2dtSaYCQzSxF8cRj_4898jLl1cZ4MP5NbqAc3jf25J8_baHD6y0-f78fByyqAuZabroiqgZn0FquuZVSA4sxUToKDopFS15LWEVPWJ6gyXkuuuUBXwStS8FFuSX28heMRgbDsHN-qwtjlrf-W0VzntVU6b5IgfjSxesw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The clinical efficacy of eribulin to soft tissue sarcoma patients: differences in histological subtypes</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Nakano, Kenji ; Funauchi, Yuki ; Hayakawa, Keiko ; Tanizawa, Taisuke ; Ae, Keisuke ; Matsumoto, Seiichi ; Takahashi, Shunji</creator><creatorcontrib>Nakano, Kenji ; Funauchi, Yuki ; Hayakawa, Keiko ; Tanizawa, Taisuke ; Ae, Keisuke ; Matsumoto, Seiichi ; Takahashi, Shunji</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz343.027</identifier><language>eng</language><ispartof>Annals of oncology, 2019-10, Vol.30, p.vi123-vi124</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Nakano, Kenji</creatorcontrib><creatorcontrib>Funauchi, Yuki</creatorcontrib><creatorcontrib>Hayakawa, Keiko</creatorcontrib><creatorcontrib>Tanizawa, Taisuke</creatorcontrib><creatorcontrib>Ae, Keisuke</creatorcontrib><creatorcontrib>Matsumoto, Seiichi</creatorcontrib><creatorcontrib>Takahashi, Shunji</creatorcontrib><title>The clinical efficacy of eribulin to soft tissue sarcoma patients: differences in histological subtypes</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotkL1OwzAUhT2ARCk8AJtfIK1jJ3HMhip-KlViyR45N3ZrlMSRrzOEp8dQpiOd8-kMHyFPOdvlTIm9niY_wX7sv0UhdozLG7JhiotMlqK4I_eIX4yxSnG1IefmYigMbnKgB2qsTQkr9Zaa4LolDTR6it5GGh3iYijqAH7UdNbRmSniM-2dtSaYCQzSxF8cRj_4898jLl1cZ4MP5NbqAc3jf25J8_baHD6y0-f78fByyqAuZabroiqgZn0FquuZVSA4sxUToKDopFS15LWEVPWJ6gyXkuuuUBXwStS8FFuSX28heMRgbDsHN-qwtjlrf-W0VzntVU6b5IgfjSxesw</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Nakano, Kenji</creator><creator>Funauchi, Yuki</creator><creator>Hayakawa, Keiko</creator><creator>Tanizawa, Taisuke</creator><creator>Ae, Keisuke</creator><creator>Matsumoto, Seiichi</creator><creator>Takahashi, Shunji</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201910</creationdate><title>The clinical efficacy of eribulin to soft tissue sarcoma patients: differences in histological subtypes</title><author>Nakano, Kenji ; Funauchi, Yuki ; Hayakawa, Keiko ; Tanizawa, Taisuke ; Ae, Keisuke ; Matsumoto, Seiichi ; Takahashi, Shunji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c857-a8464c80d6c9bd0f9c320f603c9c4b77987287c0f6dc80be2772ab496c2638253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakano, Kenji</creatorcontrib><creatorcontrib>Funauchi, Yuki</creatorcontrib><creatorcontrib>Hayakawa, Keiko</creatorcontrib><creatorcontrib>Tanizawa, Taisuke</creatorcontrib><creatorcontrib>Ae, Keisuke</creatorcontrib><creatorcontrib>Matsumoto, Seiichi</creatorcontrib><creatorcontrib>Takahashi, Shunji</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakano, Kenji</au><au>Funauchi, Yuki</au><au>Hayakawa, Keiko</au><au>Tanizawa, Taisuke</au><au>Ae, Keisuke</au><au>Matsumoto, Seiichi</au><au>Takahashi, Shunji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The clinical efficacy of eribulin to soft tissue sarcoma patients: differences in histological subtypes</atitle><jtitle>Annals of oncology</jtitle><date>2019-10</date><risdate>2019</risdate><volume>30</volume><spage>vi123</spage><epage>vi124</epage><pages>vi123-vi124</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz343.027</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2019-10, Vol.30, p.vi123-vi124
issn 0923-7534
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdz343_027
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title The clinical efficacy of eribulin to soft tissue sarcoma patients: differences in histological subtypes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T09%3A58%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20clinical%20efficacy%20of%20eribulin%20to%20soft%20tissue%20sarcoma%20patients:%20differences%20in%20histological%20subtypes&rft.jtitle=Annals%20of%20oncology&rft.au=Nakano,%20Kenji&rft.date=2019-10&rft.volume=30&rft.spage=vi123&rft.epage=vi124&rft.pages=vi123-vi124&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz343.027&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz343_027%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true